Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Effectiveness of Mobile Phone-based Distance Video Education in Individuals With Type 2 Diabetes: A Randomized Controlled Trial
| Verified date | November 2021 |
| Source | Balikesir University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This study aimed to examine the effect of mobile phone-based distance video education given to individuals with type 2 diabetes on metabolic variables and cognitive-social factors. This study is a randomized controlled trial.
| Status | Completed |
| Enrollment | 93 |
| Est. completion date | July 1, 2019 |
| Est. primary completion date | January 31, 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 65 Years |
| Eligibility | Inclusion Criteria: - Having a diagnosis of Type 2 diabetes mellitus for at least 6 months. - Being between the ages of 18-65. - Being on oral antidiabetic and/or insulin therapy. - Having a mobile phone capable of receiving and playing video messages. - Volunteering to participate in the study. - Sensory losses such as hearing and speech that will prevent communication Exclusion Criteria: - Being under 18 years of age - Not having a mobile phone capable of receiving and playing video messages - Not willing to participate in the study - Having sensory loss such as hearing and speaking that prevents communication |
| Country | Name | City | State |
|---|---|---|---|
| Turkey | Balikesir University | Balikesir | Altieylül |
| Lead Sponsor | Collaborator |
|---|---|
| Balikesir University |
Turkey,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | The Turkish Multidimensional Diabetes Questionnaire | Change from baseline diabetes-related cognitive and social factors at 3 months. Responses were on a Likert-type scale (0-not at all significant).
not, 100-very important) is marked. High school scores perceived self-efficacy and outcome indicates high expectations. |
pre-test (baseline), post-test (3 months follow-up) | |
| Secondary | HbA1C | HbA1C-change from baseline HbA1C at 3 months | pre-test (baseline), post-test (3 months follow-up) | |
| Secondary | glucose | glucose -change from baseline glucose at 3 months | pre-test (baseline), post-test (3 months follow-up) | |
| Secondary | total cholesterol | total cholesterol -change from baseline total cholesterol at 3 months | pre-test (baseline), post-test (3 months follow-up) | |
| Secondary | HDL | HDL -change from baseline HDL at 3 months | pre-test (baseline), post-test (3 months follow-up) | |
| Secondary | LDL | LDL -change from baseline LDL at 3 months | pre-test (baseline), post-test (3 months follow-up) | |
| Secondary | triglyceride | triglyceride -change from baseline triglyceride at 3 months | pre-test (baseline), post-test (3 months follow-up) |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |